Desikan Nithya 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Dec 31, 2019
Insider Transaction Report
Form 4
Desikan Nithya
Chief Commercial Officer
Transactions
- Sale
Common Stock
2019-12-27$22.79/sh−35,181$801,771→ 29,068 total - Exercise/Conversion
Common Stock
2019-12-27$6.88/sh+35,181$242,045→ 64,249 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-12-27−35,181→ 137,495 totalExercise: $6.88Exp: 2027-08-08→ Common Stock (35,181 underlying)
Footnotes (3)
- [F1]On December 27, 2019, Ms. Desikan sold 35,181 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $22.41 to $23.06, inclusive; the price reported above reflects the weighted average sale price. Ms. Desikan hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018.